Tuesday, October 17, 2023

Popular Alzheimer's drug marred in controversy as lead investigator falsified data



The co-developer of a popular Alzheimer's drug was revealed to have engaged in shady business practices.

from Daily Express :: Health Feed https://ift.tt/3g5Td06
on
Labels: ,

No comments:

Post a Comment

Thanks

Subscribe to: Post Comments (Atom)